HealthTech for Care: Applications are now open for European innovative healthcare companies for the 4th edition of the HealthTech Innovation Days (13th 14th, October 2022)
- Written by Reporters
- Biotechs that are developing a treatment currently in clinical phase;
- Medtechs that are developing a technology close to or on the market;
- Innovative service companies developing innovative products and services in high demand by healthcare players;
- Digital Health offering a product developed or under development with partners such as hospitals, pharmas or industrial companies.
About HealthTech For Care
The HealthTech For Care Endowment Fund is designed to support and promote access to healthcare for all and, more specifically, to new medical technologies and medicines. The missions of the endowment fund are organised around three main areas: to support the development of the entire healthcare ecosystem, to accelerate the development of innovative therapies and medicines, and to promote better access for patients to the healthcare system in France and Europe. The governance of HealthTech For Care includes Maryvonne Hiance, Elsy Boglioli, David Caumartin, Pierre Courteille, Eric Falcand, Frédéric Girard, Marc Julien, Cédric Moreau, Christian Pierret and Christian Policard. HealthTech For Care is supported by its founder France Biotech and the network of French health clusters: Atlanpole biotherapies, BioValley France, EuroBioMed, LyonBioPole, Medicen and the NSL clubster. The endowment fund is also supported by many European players: Asebio, BioAlps, Bio Deutschland, BioWin, CEBR, EIT Health, Federchimica Assobiotec, Flanders.bio, Flanders.HealthTech, HollandBio, Irefi, and SwissBiotech and French: BusinessFrance. https://htfc-eu.com/ #HealthTechForCare
The issuer is solely responsible for the content of this announcement.
Source https://www.media-outreach.com/news/france/2022/05/04/135138/